Results 11 to 20 of about 10,636 (185)

Correction to "Beyond Infections: A Case Report on the Identification of Neuroleptic Malignant Syndrome (NMS) in a Complex Clinical Context". [PDF]

Clin Case Rep
Clinical Case Reports, Volume 14, Issue 1, January 2026.
europepmc   +2 more sources

Aripiprazole-induced quasi-neuroleptic malignant syndrome: two case reports [PDF]

Journal of Medical Case Reports
Background Significant elevation of creatine kinase levels (above three digits) and leucocytosis in the absence of muscle rigidity, tremors, or autonomic dysfunction can pose a real challenge in the context of antipsychotic treatment as an early herald ...
Abdelgadir Hussein M. Osman, Joshua Wilkinson   +1 more
doaj   +2 more sources

Neuroleptic malignant syndrome [PDF]

Canadian Medical Association Journal, 2023
Tan, Carolyn Michelle, Kumachev, Alexander   +1 more
openaire   +3 more sources

Reintroduction of Clozapine following Neuroleptic Malignant Syndrome in a Young Patient with Resistant Schizophrenia [PDF]

Case Reports in Psychiatry
The incidence of neuroleptic malignant syndrome justifies the immediate discontinuation of the drug in question and the reinstitution of therapy with another drug.
Miriam Chandad, Rajae Chlihfane, Safae Kodad, Bouchra Oneib, Fatima Elghazouani   +4 more
doaj   +2 more sources

Tatalaksana Neuroleptik Malignant Syndrome di Intensif Care Unit dengan Impending Organ Failure [PDF]

, 2021
Neuroleptic Malignant Syndrome adalah sebuah sindrom khas dan merupakan komplikasi pengobatan antipsikotik yang mengancam jiwa. Neuroleptic Malignant Syndrome memberikan gambaran klinis seperti rigiditas, hipertermia, dan perubahan status mental ...
Fadrial, Andi Muhammad
core   +2 more sources

Fluorouracil-induced leukoencephalopathy mimicking neuroleptic malignant syndrome: a case report

Journal of Medical Case Reports, 2023
Background Fluorouracil-induced leukoencephalopathy is a rare complication and has been reported to present as confusion, oculomotor abnormality, ataxia, and parkinsonism; however, there is no previous report of a presentation mimicking neuroleptic ...
Pasin Hemachudha, Wanakorn Rattanawong, Thanakit Pongpitakmetha, Warongporn Phuenpathom   +3 more
doaj   +1 more source

Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report [PDF]

, 2012
Background: “Neuroleptic malignant syndrome” (NMS) is a potentially fatal idiosyncratic reaction to any medication which affects the central dopaminergic system. Between 0.5% and 1% of patients exposed to antipsychotics develop the condition.
AL Pelonero, BD Berman, D Berardi, D Bereardi, D Heyland, Daniel J Smith, Daniel Martin, F-GB Pajonk, H Itoh, J Ananth, J Delay, J Gill, JF Patterson, JN Trollor, JR Strawn, Julie Langan, K Otani, KL Hall, LF Viejo, LS Friedman, M Dave, MJ Bhanushali, P Adnet, P Sachdev, P Sachdev, PE Keek, PF Buckley, PI Rosebush, PJ Alexander, Polash Shajahan, RJ Gurrera, RJ Gurrera, RW Baker, S Caroff, S Madakasira   +34 more
core   +3 more sources

Neuroleptic Malignant Syndrome, with Attention to Its Occurrence with Atypical Antipsychotic Medication: A Review [PDF]

, 2006
The neuroleptic malignant syndrome (NMS) is an idiopathic, life-threatening reaction to antipsychotic medication. NMS was traditionally attributed to potent dopamine antagonism of typical antipsychotics, but cases of NMS have now been reported for each ...
Guzofski, Sarah, M.D. (PGY2), Peralta, Ruben, M.D.   +1 more
core   +2 more sources

Síndrome maligno dos neurolépticos: um caso raro de evolução prolongada.

Acta Médica Portuguesa, 2010
Neuroleptic malignant syndrome (NMS) is a neurological emergency related to neuroleptics medication. Diagnosis is clinical. Authors present the case of a 32-year-old Caucasian man with a history of moderated oligophreny treated with stable doses of ...
Joana Lemos, Marta Mós, António Monteiro, Pedro Henriques   +3 more
doaj   +1 more source

Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate

Industrial Psychiatry Journal, 2020
Zuclopenthixol is available in two parenteral formulation,i.e., in the form of acetate and decanoate. It has high affinity for dopamine D1 and D2 receptors.
Anish Shouan, Ankit Kumar Sinha, Sandeep Grover   +2 more
doaj   +1 more source